GVM±R in Patients With Relapsed or Refractory Aggressive NHL
Clinical trial NCT05299164 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05299164
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-15
- Primary completion
- 2023-12-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.